Follow the Better Therapeutics (NASDAQ:BTTX) Insiders?

etter Therapeutics, Inc. (NASDAQ:BTTX) is up nearly 40% in premarket trading this morning. While it’s still just in the $1.25 range, so it’s well below most fund’s low price threshold, this is one that risk inclined investors should keep an eye on.

Better Therapeutics, Inc. (NASDAQ:BTTX) is up nearly 40% in premarket trading this morning. While it’s still just in the $1.25 range, so it’s well below most fund’s low price threshold, this is one that risk inclined investors should keep an eye on.

Better Therapeutics’ insiders, from officers to directors, have reportedly purchased over 12 million shares to zero sales over the past 12 months (https://www.nasdaq.com/market-activity/stocks/bttx/insider-activity). Better Therapeutics insiders now own more than half of the company and, if the $10 buys are any indication, BTTX could have significant upside potential.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.